Adding nivolumab to neoadjuvant chemotherapy significantly improves response rates in high-risk early-stage ER+/HER2− breast ...
MyStateline.com on MSN7h
Utah woman receives 100 cancer treatments, living far beyond doctors’ expectationsWhen she first got her cancer diagnosis years ago, 84-year-old Dukhi Hong couldn’t have imagined coming this far. “It feels ...
The approval follows the December 2024 priority review designation for this perioperative immunotherapy regimen for patients fighting muscle-invasive bladder cancer (MIBC).
Immunotherapy is a type of cancer treatment that helps your immune system detect and fight cancer cells. Treatments may be administered via a catheter, intravenously, or by injection. There are ...
The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...
AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...
News Medical on MSN10d
Analysis of new colorectal cancer immunotherapy shows more treatment optionsA team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive ...
Researchers have revealed a new finding that could improve cancer care immunotherapy treatments, particularly for CLL and ...
Imagine a world where bacteria, typically feared for causing disease, are turned into powerful weapons against cancer. Thats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback